Update (9:47 a.m.): Updated with Thursday market open information.

NEW YORK (TheStreet) -- Bank of America/Merrill Lynch downgraded MedAssets  (MDAS) to "neutral" from "buy" and set a $24 price target. The firm cited valuation as the reason for the move.

The stock was down 2.65% to $22.79 at 9:47 a.m. on Thursday.

Must Read: Warren Buffett's 25 Favorite Stocks

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Image placeholder title

MDAS data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.